Cargando…
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
Colchicine is increasingly used as the number of potential indications expands. However, it also has a narrow therapeutic index that is associated with bothersome to severe side effects. When concomitantly use with medications inhibiting its metabolism, higher plasma levels will result and increase...
Autores principales: | Tan, Malinda S., Gomez-Lumbreras, Ainhoa, Villa-Zapata, Lorenzo, Malone, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473467/ https://www.ncbi.nlm.nih.gov/pubmed/36104598 http://dx.doi.org/10.1007/s00296-022-05201-5 |
Ejemplares similares
-
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022) -
Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021) -
COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database
por: Villa-Zapata, Lorenzo, et al.
Publicado: (2023) -
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023) -
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)